Idiopathic Inflammatory Myopathies
The Idiopathic Inflammatory Myopathies pipeline: 4 tracked drugs, 2 approved for this indication.
Coverage in progress. The assets here come from their companies' published pipelines. AssetMemo has not yet run its full census of every drug in development for Idiopathic Inflammatory Myopathies, so this list is not complete.
2 approved / phase 41 Phase 31 Phase 1
Compare the share prices of listed companies in Idiopathic Inflammatory Myopathies →
Market size not yet sourced. How markets are sized ↗